FLEURY S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.05 BRL | +0.29% |
|
-1.20% | -22.12% |
| May. 10 | Fleury Seeks Acquisitions | CI |
| May. 10 | Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024 |
ETFs positioned on Fleury S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 2 M€ | -14.14% | ||
| 0.24% | 14 M€ | -4.02% | ||
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 112 M€ | +4.61% | - | |
| 0.00% | 45 M€ | -.--% | - | |
| 0.00% | 7 M€ | +5.36% | - | |
| 0.00% | 34 M€ | +3.86% | - |
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
2024-06-04
- Bradesco BBI London Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
14.05
BRL
Average target price
19.33
BRL
Spread / Average Target
+37.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.12% | 1.48B | |
| -24.16% | 7.66B | |
| +68.65% | 4.35B | |
| +2.72% | 2.62B | |
| -2.98% | 2.53B | |
| -46.17% | 2.21B | |
| -15.27% | 1.79B | |
| +13.62% | 1.18B | |
| -43.81% | 1.13B | |
| +20.41% | 997M |
- Stock Market
- Equities
- FLRY3 Stock
- Funds and ETFs Fleury S.A.
